Search Results for citation:"90 FR 7173"

Found 2 results
Skip to main content

Search Results: citation:"90 FR 7173"

  • Type:Notice
    Citation:90 FR 7173
    Reading Time:about a minute or two

    Invizyne Technologies, Inc. has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of certain controlled substances, including synthetic Tetrahydrocannabinols. Stakeholders, such as current manufacturers and applicants, can submit comments or objections electronically through the Federal eRulemaking Portal by March 24, 2025, and may also request a hearing by the same date. The DEA has provided detailed instructions for submitting comments online and has assured that comments will receive a Comment Tracking Number upon successful submission.

    Simple Explanation

    Invizyne Technologies, Inc. wants to make a special kind of medicine and they're asking permission from a big government team called the DEA. People who have something to say about this can write in their thoughts or ask for a meeting before March 24, 2025.

  • Type:Notice
    Citation:90 FR 7173
    Reading Time:about a minute or two

    The Drug Enforcement Administration (DEA) has announced that Siegfried USA, LLC, located in Pennsville, New Jersey, has applied to be registered as a bulk manufacturer of certain controlled substances. Interested parties, including registered manufacturers of these substances, can submit comments or objections electronically by March 24, 2025. They can also request a hearing on the application by the same date. This registration will allow Siegfried USA to produce these substances in bulk for sale.

    Simple Explanation

    Siegfried USA, a company in New Jersey, wants permission to make special medicine ingredients in large amounts, and people can tell the government what they think about this by March 24, 2025.